US Patent 7781182 Ubiquitin ligase assay
Patent 7781182 was granted and assigned to Rigel Pharmaceuticals on August, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+146 characters)
Article
Patent abstract
The invention relates to assays for measuring ubiquitin ligase activity and for identifying modulators of ubiquitin ligase enzymes.
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07781182 Ubiquitin ligase assay US Patent 7781182 Ubiquitin ligase assay
Infobox
Patent Number
0778118200
Patent Number
778118200
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 30 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
077811820
Date of Patent
August 24, 2010
0Patent Application Number
113287470
Date Filed
January 9, 2006
0Official Website
Patent Primary Examiner
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
077811820
Date of Patent
August 24, 2010
0Patent Application Number
113287470
Date Filed
January 9, 2006
0Official Website
Patent Primary Examiner
Edits on 3 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 5 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07781182 Ubiquitin ligase assay
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07781182
Date of patent
August 24, 2010
Patent application number
11328747
Date Filed
January 9, 2006
Patent primary examiner
Find more entities like US Patent 7781182 Ubiquitin ligase assay
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.